The FDA called the shortage over in early 2025, pushing compounders out while brand-name prices left many patients paying more.
Recap by typeshit. Post by Facebook on Facebook.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
KTSM breaks down which Medicare enrollees are eligible for GLP-1 drugs at a $50 monthly cost.
Men's Journal looks at the extra spending that comes with GLP-1 drugs beyond the prescription price, as these meds reshape weight loss.
The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
A BusinessWorld piece on tirzepatide, semaglutide and retatrutide and where each stands with the FDA. Little detail was available beyond the topic.
Negotiated Medicare prices on 15 drugs, Ozempic, Wegovy and Trelegy among them, take effect in 2027. The full list of drugs and discounts is at the link.
Loading…